---
title: Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia,
  and HFpEF
date: '2024-09-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39329430/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240927184334&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Heart failure (HF) is a complex and heterogeneous syndrome
  resulting from any diastolic or systolic dysfunction of the cardiac muscle. In addition
  to comorbid conditions, pressure overload, and myocardial ischemia are associated
  with cardiac remodeling which manifests as extracellular matrix (ECM) perturbations,
  impaired cellular responses, and subsequent ventricular ...'
disable_comments: true
---
INTRODUCTION: Heart failure (HF) is a complex and heterogeneous syndrome resulting from any diastolic or systolic dysfunction of the cardiac muscle. In addition to comorbid conditions, pressure overload, and myocardial ischemia are associated with cardiac remodeling which manifests as extracellular matrix (ECM) perturbations, impaired cellular responses, and subsequent ventricular ...